| The prescription medication business is booming. Nearly 70% of Americans report that they take at least one prescription medication daily. And approximately one in five takes four or more meds a day. The majority of those taking prescriptions – 82% – say the cost is "unreasonable," and for those taking multiple prescriptions, nearly 40% say they have trouble affording their medication. Couple all those factors with inflation, and consumers are desperately looking for a cost-effective way to access their medications. For some, it's a matter of life and death. Plenty of tech-driven healthcare companies offer a solution, but not all will emerge as winners. That's why you have MegaTrends in your corner. Our Social Heat Score device can tap into America's collective consciousness to identify the opportunities gaining traction on Main Street so we can bring them to you here. And today, it's "prescribing" GoodRX (GDRX) as a buy with a bullish Social Heat Score of 74. 
GoodRx is leveraging technology and its user-friendly app to help consumers save money on what they need most, and all signs point to healthy growth ahead. Take a look at how GDRX is outperforming the competition and why we believe this stock could surge 150% in the next two years... Access full buy alert | 
Tidak ada komentar:
Posting Komentar